|
Volumn 155, Issue 1, 2006, Pages 152-155
|
Tacrolimus ointment 0.1% in pityriasis alba: An open-label, randomized, placebo-controlled study
|
Author keywords
Adverse effects; Atopy; Pityriasis alba; Randomized controlled trial; Tacrolimus; Treatment
|
Indexed keywords
SUNSCREEN;
TACROLIMUS;
ADOLESCENT;
ADULT;
ARTICLE;
BURNING SENSATION;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE CLASSIFICATION;
DRUG EFFICACY;
DRUG SAFETY;
DRY SKIN;
ERYTHEMA STREPTOGENES;
FEMALE;
HUMAN;
HYPOPIGMENTATION;
MALE;
PATIENT SATISFACTION;
PITYRIASIS;
PRIORITY JOURNAL;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL SIGNIFICANCE;
ADOLESCENT;
ADULT;
ANALYSIS OF VARIANCE;
CHILD;
DERMATOLOGIC AGENTS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
HYPOPIGMENTATION;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
PITYRIASIS;
PRURITUS;
SKIN;
STATISTICS, NONPARAMETRIC;
SUNSCREENING AGENTS;
TACROLIMUS;
|
EID: 33745012624
PISSN: 00070963
EISSN: 13652133
Source Type: Journal
DOI: 10.1111/j.1365-2133.2006.07181.x Document Type: Article |
Times cited : (34)
|
References (9)
|